The role of mast cells in male infertility

Expert Review of Clinical Immunology

Volumn 7, Issue 5, 2011, Pages 627-634

  Haidl, Gerd ^a   Duan, Yong Gang ^a   Chen, Shu Jian ^a   Kohn, Frank Michael ^b   Schuppe, Hans Christian ^c   Allam, Jean Pierre ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Andrologicum Munich   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

genital tract inflammation; male infertility; mast cell; spermatogenesis; testis

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHYMASE; FEXOFENADINE; HEPARIN; HISTAMINE; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 9; KETOTIFEN; PROSTAGLANDIN; SEROTONIN; STEM CELL FACTOR; TRANILAST; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ASTHENOSPERMIA; AZOOSPERMIA; BLOOD CELL COUNT; BLOOD TESTIS BARRIER; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN; DENDRITIC CELL; EPIDIDYMIS; FLOW CYTOMETRY; HUMAN; IMMUNOCOMPETENT CELL; MALE INFERTILITY; MAST CELL; MAST CELL DEGRANULATION; OLIGOSPERMIA; ORCHITIS; PELVIS PAIN SYNDROME; PREGNANCY RATE; PROSTATE; PROSTATITIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEMINAL PLASMA; SEMINAL VESICLE; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; T LYMPHOCYTE; TESTIS;

ANIMALS; BLOOD-TESTIS BARRIER; HUMANS; INFERTILITY, MALE; INFLAMMATION; MALE; MAST CELLS; SEMEN;

EID: 80052613654     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.57     Document Type: Review

References (93)

1. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev. 217, 304-328 (2007). (Pubitemid 46718153)
2. Hermo L, Lalli M. Monocytes and mast cells in the limiting membrane of human seminiferous tubules. Biol. Reprod. 19(1), 92-100 (1978). (Pubitemid 8392735)
3. Behrendt H, Hilscher B, Passia D, Hofmann N, Hilscher W. The occurrence of mast cells in the human testis. Acta Anat. 111, 14-16 (1981).
4. Maseki Y, Miyake K, Mitsuya H, Kitamura H, Yamada K. Mastocytosis occurring in the testes from patients with idiopathic male infertility. Fertil. Steril. 36(6), 814-817 (1981). (Pubitemid 12193603)
5. Nistal M, Santamaria L, Paniagua R. Mast cells in the human testis and epididymis from birth to adulthood. Acta Anat. (Basel) 119(3), 155-160 (1984). (Pubitemid 14111948)
6. Frungieri MB, Calandra RS, Lustig L et al. Number, distribution pattern, and identification of macrophages in the testes of infertile men. Fertil. Steril. 78(2), 298-306 (2002). (Pubitemid 34831730)
7. Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Adv. Immunol. 95, 167-255 (2007). (Pubitemid 47380506)
8. Pejler G, Ronnberg E, Waern I, Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 115(24), 4981-4990 (2010).
9. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 420(6917), 875-878 (2002). (Pubitemid 36019641)
10. Malaviya R, Georges A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin. Rev. Allergy Immunol. 22(2), 189-204 (2002). (Pubitemid 34264096)
11. Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40(7), 1843-1851 (2010).
12. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10(6), 440-452 (2010).
13. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol. Rev. 173, 131-140 (2000). (Pubitemid 30095217)
14. Metz M, Maurer M. Mast cells - key effector cells in immune responses. Trends Immunol. 28(5), 234-241 (2007). (Pubitemid 46654869)
15. Abraham SN, Malaviya R. Mast cells in infection and immunity. Infect. Immun. 65(9), 3501-3508 (1997). (Pubitemid 27398100)
16. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 271(5250), 818-822 (1996). (Pubitemid 26058936)
17. Galli SJ, Hammel I. Mast cell and basophil development. Curr. Opin. Hematol. 1(1), 33-39 (1994).
18. Abonia JP, Austen KF, Rollins BJ et al. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105(11), 4308-4313 (2005). (Pubitemid 40720777)
19. Hogan AD, Schwartz LB. Markers of mast cell degranulation. Methods 13(1), 43-52 (1997). (Pubitemid 27453065)
20. Nakae S, Suto H, Berry GJ, Galli SJ. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109(9), 3640-3648 (2007). (Pubitemid 46641710)
21. Oliveira SH, Lukacs NW. Stem cell factor and IgE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm. Res. 50(3), 168-174 (2001). (Pubitemid 32242706)
22. Moon TC, St Laurent CD, Morris KE et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal. Immunol. 3(2), 111-128 (2010).
23. Fijak M, Meinhardt A. The testis in immune privilege. Immunol. Rev. 213, 66-81 (2006). (Pubitemid 44401494)
24. Damazo A, Paul-Clark M, Straus A, Takahashi H, Perretti M, Oliani S. Analysis of annexin 1 expression in rat trachea: study of the mast cell heterogeneity. Annexins 1, 12-18 (2004).
25. De Jonge F, Van Nassauw L, Van Meir F, Miller HR, Van Marck E, Timmermans JP. Temporal distribution of distinct mast cell phenotypes during intestinal schistosomiasis in mice. Parasite Immunol. 24(5), 225-231 (2002). (Pubitemid 34639191)
26. Kawakubo K, Akiba Y, Adelson D et al. Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats. Peptides 26(9), 1580-1589 (2005). (Pubitemid 41169751)
27. Yamanaka K, Fujisawa M, Tanaka H, Okada H, Arakawa S, Kamidono S. Significance of human testicular mast cells and their subtypes in male infertility. Hum. Reprod. 15(7), 1543-1547 (2000).
28. Enerback L. The differentiation and maturation of inflammatory cells involved in the allergic response: mast cells and basophils. Allergy 52(1), 4-10 (1997). (Pubitemid 27120619)
29. Dohle GR, Colpi GM, Hargreave TB, Papp GK, Jungwirth A, Weidner W. EAU guidelines on male infertility. Eur. Urol. 48(5), 703-711 (2005). (Pubitemid 41508883)
30. Tuttelmann F, Nieschlag E. Classification of andrological disorders. In:Andrology: Male Reproductive Health and Dysfunction. Nieschlag E, Behre HM, Nieschlag S (Eds).Springer, NY, USA, 90-96 (2009).
31. Schuppe HC, Meinhardt A, Allam JP, Bergmann M, Weidner W, Haidl G. Chronic orchitis: a neglected cause of male infertility? Andrologia 40(2), 84-91 (2008). (Pubitemid 351379679)
32. Haidl G, Allam JP, Schuppe HC. Chronic epididymitis: impact on semen parameters and therapeutic options. Andrologia 40(2), 92-96 (2008). (Pubitemid 351379664)
33. Schuppe HC, Meinhardt A. Immune privilege and inflammation of the testis. Chem. Immunol. Allergy 88, 1-14 (2005).
34. Hedger MP. Testicular leukocytes: what are they doing? Rev. Reprod. 2(1), 38-47 (1997). (Pubitemid 27165965)
35. Weidner W, Krause W, Ludwig M. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum. Reprod. Update 5(5), 421-432 (1999). (Pubitemid 29512130)
36. Doncel GF, Di Paola JA, Lustig L. Sequential study of the histopathology and cellular and humoral immune response during the development of an autoimmune orchitis in Wistar rats. Am. J. Reprod. Immunol. 20(2), 44-51 (1989). (Pubitemid 19275827)
37. Suescun MO, Rival C, Theas MS, Calandra RS, Lustig L. Involvement of tumor necrosis factor-α in the pathogenesis of autoimmune orchitis in rats. Biol. Reprod. 68(6), 2114-2121 (2003). (Pubitemid 36687003)
38. Rival C, Lustig L, Iosub R et al. Identification of a dendritic cell population in normal testis and in chronically inflamed testis of rats with autoimmune orchitis. Cell Tissue Res. 324(2), 311-318 (2006).
39. Anton F, Morales C, Aguilar R, Bellido C, Aguilar E, Gaytan F. A comparative study of mast cells and eosinophil leukocytes in the mammalian testis. Zentralbl. Veterinarmed. A. 45(4), 209-218 (1998). (Pubitemid 128530599)
40. Meineke V, Frungieri MB, Jessberger B, Vogt H, Mayerhofer A. Human testicular mast cells contain tryptase: increased mast cell number and altered distribution in the testes of infertile men. Fertil. Steril. 74(2), 239-244 (2000). (Pubitemid 30604184)
41. Hussein MR, Abou-Deif ES, Bedaiwy MA et al. Phenotypic characterization of the immune and mast cell infiltrates in the human testis shows normal and abnormal spermatogenesis. Fertil. Steril. 83(5), 1447-1453 (2005). (Pubitemid 40615819)
42. Schuppe HC, Neumann N, Schock-Skasa G, Scheffzyk A, Schill WB. Mast cells in testicular inflammatory reactions: conductors, players, or innocent bystanders? Andrologia 34, 152 (2002) (Abstract).
43. Iosub R, Klug J, Fijak M et al. Development of testicular inflammation in the rat involves activation of proteinase-activated receptor-2. J. Pathol. 208(5), 686-698 (2006).
44. Walsh LJ. Mast cells and oral inflammation. Crit. Rev. Oral Biol. Med. 14(3), 188-198 (2003). (Pubitemid 44560803)
45. Jimenez-Trejo F, Tapia-Rodriguez M, Queiroz DB et al. Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation and variations associated with adult mating status: morphological and biochemical studies. J. Androl. 28(1), 136-149 (2007). (Pubitemid 46048086)
46. Apa DD, Cayan S, Polat A, Akbay E. Mast cells and fibrosis on testicular biopsies in male infertility. Arch. Androl. 48(5), 337-344 (2002). (Pubitemid 34856525)
47. Hofmann N, Klasa M, Behrendt H et al. Appearance of mast cells in human testis with sertoli cell only syndrome. In:Fortschritte der Andrologie. Schirren C (Ed.).Grosse, Berlin, Germany, 122-129 (1983).
48. Bergmann M. Evaluation of testicular biopsy samples from the clinical perspective. In:Andrology for the Clinician. Schill WB, Comhaire FH, Hargreave TB (Eds).Springer, Heidelberg, Germany, 454-461 (2006).
49. McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Kretser DM, Skakkebaek NE. Histological evaluation of the human testis - approaches to optimizing the clinical value of the assessment: mini review. Hum. Reprod. 22(1), 2-16 (2007). (Pubitemid 44942661)
50. Jezek D, Banek L, Hittmair A, Pezerovic- Panijan R, Goluza T, Schulze W. Mast cells in testicular biopsies of infertile men with 'mixed atrophy' of seminiferous tubules. Andrologia 31(4), 203-210 (1999). (Pubitemid 29362063)
51. Roaiah MM, Khatab H, Mostafa T. Mast cells in testicular biopsies of azoospermic men. Andrologia 39(5), 185-189 (2007). (Pubitemid 351547012)
52. Haidl G. Which efforts towards conservative treatment of male infertility will be successful? Mast cell blockers. Andrologia 31(5), 299-300 (1999). (Pubitemid 29446422)
53. Nagai T, Takaba H, Miyake K, Hirabayashi Y, Yamada K. Testicular mast cell heterogeneity in idiopathic male infertility. Fertil. Steril. 57(6), 1331-1336 (1992).
54. Weidinger S, Mayerhofer A, Kunz L et al. Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway. Hum. Reprod. 20(2), 456-461 (2005). (Pubitemid 40277617)
55. Steinhoff M, Vergnolle N, Young SH et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6(2), 151-158 (2000). (Pubitemid 30082358)
56. Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARg: Possible relevance to human fibrotic disorders. Proc. Natl Acad. Sci. USA 99(23), 15072-15077 (2002). (Pubitemid 35334611)
57. Albrecht M, Frungieri MB, Gonzalez-Calvar S, Meineke V, Kohn FM, Mayerhofer A. Evidence for a histaminergic system in the human testis. Fertil. Steril. 83(4), 1060-1063 (2005).
58. Levi-Schaffer F, Piliponsky AM. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 24(4), 158-161 (2003). (Pubitemid 36412097)
59. Hedger MP, Meinhardt A. Cytokines and the immune-testicular axis. J. Reprod. Immunol. 58(1), 1-26 (2003). (Pubitemid 36279148)
60. Smith TJ, Parikh SJ. HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. Endocrinology 140(8), 3518-3525 (1999). (Pubitemid 30645407)
61. Duan YG, Yu CF, Novak N et al. Immunodeviation towards a Th17 immune response associated with testicular damage in azoospermic men. Int. J. Androl. DOI:10.1111/j.1365-2605.2010.01137.x. (2011) (Epub ahead of print).
62. Stephan JP, Syed V, Jegou B. Regulation of sertoli cell IL-1 and IL-6 production in vitro. Mol. Cell Endocrinol. 134(2), 109-118 (1997). (Pubitemid 27510877)
63. Rival C, Theas MS, Suescun MO et al. Functional and phenotypic characteristics of testicular macrophages in experimental autoimmune orchitis. J. Pathol. 215(2), 108-117 (2008). (Pubitemid 351786029)
64. Hedger MP, Hales DB. Immunophysiology of the male reproductive tract. In:Knobil and Neill's Physiology of Reproduction. Neill JD (Ed.).Elsevier Inc., Amsterdam, The Netherlands, 1195-1286 (2006).
65. Gaytan F, Carrera G, Pinilla L, Aguilar R, Bellido C. Mast cells in the testis, epididymis and accessory glands of the rat: effects of neonatal steroid treatment. J. Androl. 10(5), 351-358 (1989). (Pubitemid 19266889)
66. Theoharides TC, Flaris N, Cronin CT, Ucci A, Meares E. Mast cell activation in sterile bladder and prostate inflammation. Int. Arch. Allergy Appl. Immunol. 92(3), 281-286 (1990).
67. Gupta RK. Mast cell variations in prostate and urinary bladder. Arch. Pathol. 89(4), 302-305 (1970).
68. Keith IM, Jin J, Neal D Jr, Teunissen BD, Moon TD. Cell relationship in a Wistar rat model of spontaneous prostatitis. J. Urol. 166(1), 323-328 (2001). (Pubitemid 32565420)
69. Bankl HC, Samorapoompichit P, Pikula B et al. Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. Am. J. Clin. Pathol. 116(1), 97-106 (2001). (Pubitemid 32601133)
70. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 179(Suppl. 5), S61-S67 (2008). (Pubitemid 351483916)
71. Ellem SJ, Wang H, Poutanen M, Risbridger GP. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am. J. Pathol. 175(3), 1187-1199 (2009).
72. Fibbi B, Penna G, Morelli A, Adorini L, Maggi M. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int. J. Androl. 33(3), 475-488 (2010).
73. Mendes LO, Amorim JP, Teixeira GR et al. Mast cells and ethanol consumption: interactions in the prostate, epididymis and testis of UChB rats. Am. J. Reprod. Immunol. 66(3), 170-178 (2011).
74. El-Karaksy A, Mostafa T, Shaeer OK, Bahgat DR, Samir N. Seminal mast cells in infertile asthenozoospermic males. Andrologia 39(6), 244-247 (2007). (Pubitemid 351738022)
75. Allam JP, Langer M, Fathy A et al. Mast cells in the seminal plasma of infertile men as detected by flow cytometry. Andrologia 41(1), 1-6 (2009).
76. Weidinger S, Mayerhofer A, Frungieri MB, Meineke V, Ring J, Kohn FM. Mast cell-sperm interaction: evidence for tryptase and proteinase-activated receptors in the regulation of sperm motility. Hum. Reprod. 18(12), 2519-2524 (2003). (Pubitemid 37536615)
77. Schill WB, Schneider J, Ring J. The use of ketotifen, a mast cell blocker, for treatment of oligo- and asthenozoospermia. Andrologia 18(6), 570-573 (1986). (Pubitemid 17188115)
78. Yamamoto M, Hibi H, Miyake K. Appearance of spermatozoon after administration of mast cell blocker to a patient with azoospermia. Hinyokika Kiyo 40(6), 541-543 (1994).
79. Yamamoto M, Hibi H, Miyake K. New treatment of idiopathic severe oligozoospermia with mast cell blocker: results of a single-blind study. Fertil. Steril. 64(6), 1221-1223 (1995).
80. Hibi H, Kato K, Mitsui K et al. The treatment with tranilast, a mast cell blocker, for idiopathic oligozoospermia. Arch. Androl. 47(2), 107-111 (2001). (Pubitemid 32802879)
81. Matsuki S, Sasagawa I, Suzuki Y et al. The use of ebastine, a mast cell blocker, for treatment of oligozoospermia. Arch. Androl. 44(2), 129-132 (2000). (Pubitemid 30159904)
82. Cayan S, Apa DD, Akbay E. Effect of fexofenadine, a mast cell blocker, in infertile men with significantly increased testicular mast cells. Asian J. Androl. 4(4), 291-294 (2002). (Pubitemid 36113998)
83. Oliva A, Multigner L. Ketotifen improves sperm motility and sperm morphology in male patients with leukocytospermia and unexplained infertility. Fertil. Steril. 85(1), 240-243 (2006). (Pubitemid 43063459)
84. Azadi L, Abbasi H, Deemeh MR et al. Zaditen (Ketotifen), as mast cell blocker, improves sperm quality, chromatin integrity and pregnancy rate after varicocelectomy. Int. J. Androl. DOI:10.1111/j.1365-2605.2010.0111-2.x. (2010) (Epub ahead of print).
85. Ma K, Mallidis C, Bhasin S. The role of Y chromosone deletions in male infertility. Eur. J. Endocrinol. 142(5), 418-430 (2000). (Pubitemid 30341171)
86. Clarnette T, Hutson J. Congential testicular maldescent. Br. J. Urol. 77(4), 619-620 (1996).
87. Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J. Natl Cancer Inst. Monogr. 34(3), 6-8 (2005).
88. Dokmeci D. Testicular torsion, oxidative stress and the role of anti-oxidant therapy. Folia. Med. (Plovdiv) 48(3-4), 16-21 (2006).
89. Romeo C, Santoro G. Varicocele and infertility: why a prevention? J. Endocrinol. Invest. 32(6), 559-561 (2009).
90. Matsumiya K, Namiki M, Takahara S et al. Clinical study of azoospermia. Int. J. Androl. 17(3), 140-142 (1994). (Pubitemid 24213161)
91. Winter C, Albers P. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol. 7(1), 43-53 (2011).
92. Palit V, Eardley I. An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat. Rev. Urol. 7(11), 603-609 (2010).
93. Wang MH, Baskin LS. Endocrine disruptors, genital development, and hypospadias. J. Androl. 29(5), 499-505 (2008).